Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05484882 · ClinicalTrials.gov registry record

Genomics, Environmental Factors and Social Determinants of Cardiovascular Disease in African-Americans Study (GENE-FORECAST): Prospective COVID-19 Natural History Study

A clinical trial, sponsored by National Human Genome Research Institute (NHGRI).

Completed
Registry status
431
Enrollment target

NCT05484882 is a clinical trial that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 431 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05484882 has completed, sponsored by National Human Genome Research Institute (NHGRI).

COMPLETED
Registry status
431 participants
Enrollment target

Study Summary

Background: The COVID-19 pandemic infected and killed African Americans at higher rates than other Americans. Researchers want to understand why. Objective: This natural history study will look at how genetic, environmental, and social factors may predict or affect COVID-19 in African Americans. Information from this study will be combined with data from the GENE-FORECAST study. Eligibility: African Americans who were previously enrolled in GENE-FORECAST. Design: The study includes a telephone interview and 1 visit to the NIH clinic. Participants may engage in either one or both of these activities. The telephone interview will last 20 minutes. Participants will talk about their experiences during the COVID-19 pandemic. The clinic visit will last up to 4 hours. Participants will have a physical exam. They will have blood and urine tests. They will be tested for COVID-19. A long swab will be inserted into a nostril to get a fluid sample from the back of the nose. They will have noninvasive tests of their blood vessels. One device used is a pen-like probe placed lightly on the wrist. Another is a rubber sleeve placed around a finger while a blood pressure cuff is used on the arm. Participants will have a test to measure the electrical activity in their heart. Stickers attached to wires will be placed on their chest, arms, and legs. Participants will answer more questions about COVID-19. They will talk about their health behavior. They will talk about their family's health and the neighborhood they live in. Other questions will ask how they feel, live, work, and play.

Trial Details

FieldValue
Enrollment Target 431 participants
Start Date 2023-02-18
Est. Completion 2023-06-26

What the Registry Record Tells You About NCT05484882

The ClinicalTrials.gov registry entry for NCT05484882 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 431 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Human Genome Research Institute (NHGRI), which has 185 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT05484882 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05484882 about?

NCT05484882 is a clinical study titled "Genomics, Environmental Factors and Social Determinants of Cardiovascular Disease in African-Americans Study (GENE-FORECAST): Prospective COVID-19 Natural History Study". Background: The COVID-19 pandemic infected and killed African Americans at higher rates than other Americans. Researchers want to understand why. Objective: This natural history study will look at how genetic, environmental, and social factors may predict or affect COVID-19 in African Americans. ...

What is the current status of trial NCT05484882?

This trial is currently completed. The enrollment target is 431 participants. The study started on 2023-02-18. Estimated completion is 2023-06-26.

Who is sponsoring clinical trial NCT05484882?

This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.